DOI: 10.1128/AAC.04215-14
Article Information
PubMed
Published By
History
- Received September 3, 2014
- Returned for modification October 6, 2014
- Accepted November 21, 2014
- Published online January 27, 2015.
Copyright & Usage
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (November 24, 2014).
- You are viewing the most recent version of this article.
Author Information
- Adriaan E. Bassona,b,
- Soo-Yon Rheec,
- Chris M. Parryd,e,f,
- Ziad El-Khatiba,g,
- Salome Charalamboush,
- Tulio De Oliveirai,
- Deenan Pillayd,e,
- Christopher Hoffmannh,j,
- David Katzensteinc,
- Robert W. Shaferc and
- Lynn Morrisa,b
- aCentre for HIV and STIs, National Institute for Communicable Diseases (NICD), part of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
- bUniversity of the Witwatersrand, Johannesburg, South Africa
- cDivision of Infectious Diseases, Stanford University Medical Center, Stanford, California, USA
- dAntiviral Unit Virus Reference Department, Health Protection Agency (HPA), London, United Kingdom
- eMRC/UCL Center for Medical Molecular Virology, UCL, London, United Kingdom
- fMRC/UVRI Research Unit on AIDS, Uganda Virus Research Institute, Entebbe, Uganda
- gDepartment of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
- hThe Aurum Institute, Johannesburg, South Africa
- iAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa
- jJohns Hopkins University, Center for TB Research, School of Medicine, Baltimore, Maryland, USA
- Address correspondence to Lynn Morris, lynnm{at}nicd.ac.za.
Citation Basson AE, Rhee S-Y, Parry CM, El-Khatib Z, Charalambous S, De Oliveira T, Pillay D, Hoffmann C, Katzenstein D, Shafer RW, Morris L. 2015. Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother 59:960–971. doi:10.1128/AAC.04215-14.
